1	Una	Una		C0205447_1	calificador_1	0-3	161_QUEST_clinical_caseMIR	SENT1	-	-
2	mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	4-9	161_QUEST_clinical_caseMIR	SENT1	-	-
3	de	de	SPS00	C0332285	atributo	10-12	161_QUEST_clinical_caseMIR	SENT1	-	-
4	33	33		-	-	13-15	161_QUEST_clinical_caseMIR	SENT1	-	-
5	años	año	NCMP000	C0439234	calificador	16-20	161_QUEST_clinical_caseMIR	SENT1	-	-
6	consulta	consultar	VMM02S0	C1704447_1	calificador_1	21-29	161_QUEST_clinical_caseMIR	SENT1	-	-
7	por	por	SPS00	C1704447_2	calificador_2	30-33	161_QUEST_clinical_caseMIR	SENT1	-	-
8	epistaxis	epistaxis	NCFN000	C0014591	trastorno	34-43	161_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
9	de	de	SPS00	C0332285	atributo	44-46	161_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
10	repetición	repetición	NCFS000	-	-	47-57	161_QUEST_clinical_caseMIR	SENT1	I-Calificador	-
11	,	,	Fc	-	-	57-58	161_QUEST_clinical_caseMIR	SENT1	-	-
12	petequias	petequia	NCFP000	C0031256	anomalía_morfológica	59-68	161_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
13	y	y	CC	C1706368	calificador	69-70	161_QUEST_clinical_caseMIR	SENT1	-	-
14	equimosis	equimosis	NCFN000	C0013491	anomalía_morfológica#hallazgo	71-80	161_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
15	.	.	Fp	-	-	80-81	161_QUEST_clinical_caseMIR	SENT1	-	-

1	Las	el	DA0FP0	-	-	82-85	161_QUEST_clinical_caseMIR	SENT2	-	-
2	pruebas	prueba	NCFP000	-	-	86-93	161_QUEST_clinical_caseMIR	SENT2	-	-
3	de	de	SPS00	C0332285	atributo	94-96	161_QUEST_clinical_caseMIR	SENT2	-	-
4	laboratorio	laboratorio	NCMS000	C0022877	medio_ambiente	97-108	161_QUEST_clinical_caseMIR	SENT2	-	-
5	muestran	mostrar	VMIP3P0	-	-	109-117	161_QUEST_clinical_caseMIR	SENT2	-	-
6	trombocitopenia	trombocitopenia	NC00SC0	C0040034_1	trastorno#hallazgo_1	118-133	161_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
7	con	con	SPS00	C0332287	atributo	134-137	161_QUEST_clinical_caseMIR	SENT2	-	-
8	un	un		C0205447_1	calificador_1	138-140	161_QUEST_clinical_caseMIR	SENT2	-	-
9	recuento	recuento	NCMS000	-	-	141-149	161_QUEST_clinical_caseMIR	SENT2	-	-
10	plaquetario	plaquetario	AQ0MS0	-	-	150-161	161_QUEST_clinical_caseMIR	SENT2	-	-
11	de	de	SPS00	C0332285	atributo	162-164	161_QUEST_clinical_caseMIR	SENT2	-	-
12	4000	4000		-	-	165-169	161_QUEST_clinical_caseMIR	SENT2	-	-
13	plaque	plaque	NCMS000	-	-	170-176	161_QUEST_clinical_caseMIR	SENT2	-	-
14	­	­	Fz	-	-	176-177	161_QUEST_clinical_caseMIR	SENT2	-	-
15	tas	tas	NCMN000	-	-	177-180	161_QUEST_clinical_caseMIR	SENT2	-	-
16	/	/	Fh	-	-	180-181	161_QUEST_clinical_caseMIR	SENT2	-	-
17	microlitro	microlitro	NC00SC0	C0439243	calificador	181-191	161_QUEST_clinical_caseMIR	SENT2	-	-
18	.	.	Fp	-	-	191-192	161_QUEST_clinical_caseMIR	SENT2	-	-

1	El	el	DA0MS0	-	-	193-195	161_QUEST_clinical_caseMIR	SENT3	-	-
2	diagnóstico	diagnóstico	NCMS000	C0011900	entidad_observable	196-207	161_QUEST_clinical_caseMIR	SENT3	-	-
3	de	de	SPS00	C0332285	atributo	208-210	161_QUEST_clinical_caseMIR	SENT3	-	-
4	presunción	presunción	NCFS000	-	-	211-221	161_QUEST_clinical_caseMIR	SENT3	-	-
5	inicial	inicial	AQ0CS0	C0205265	calificador	222-229	161_QUEST_clinical_caseMIR	SENT3	-	-
6	es	ser	VSIP3S0	-	-	230-232	161_QUEST_clinical_caseMIR	SENT3	-	-
7	de	de	SPS00	C0332285	atributo	233-235	161_QUEST_clinical_caseMIR	SENT3	-	-
8	púrpura	púrpura	NCMS000	C0857305_1	trastorno_1	236-243	161_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
9	trombocitopénica	trombocitopénica		C0857305_2	trastorno_2	244-260	161_QUEST_clinical_caseMIR	SENT3	B-Calificador	-
10	inmuni	inmuni	RG	-	-	261-267	161_QUEST_clinical_caseMIR	SENT3	B-Calificador	-
11	­	­	Fz	-	-	267-268	161_QUEST_clinical_caseMIR	SENT3	-	-
12	taria	taria	AQ0FS00	-	-	268-273	161_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
13	crónica	crónica	NCFS000	-	-	274-281	161_QUEST_clinical_caseMIR	SENT3	B-Calificador	-
14	(	(	Fpa	-	-	282-283	161_QUEST_clinical_caseMIR	SENT3	-	-
15	PTI	pti	NC00YL0	C0398650_1	trastorno_1	283-286	161_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
16	)	)	Fpt	-	-	286-287	161_QUEST_clinical_caseMIR	SENT3	-	-
17	.	.	Fp	-	-	287-288	161_QUEST_clinical_caseMIR	SENT3	-	-

1	¿	¿	Fia	-	-	289-290	161_QUEST_clinical_caseMIR	SENT4	-	-
2	Cuál	cuál	PT0CS000	-	-	290-294	161_QUEST_clinical_caseMIR	SENT4	-	-
3	de	de	SPS00	C0332285	atributo	295-297	161_QUEST_clinical_caseMIR	SENT4	-	-
4	las	el	DA0FP0	-	-	298-301	161_QUEST_clinical_caseMIR	SENT4	-	-
5	siguientes	siguiente	AQ0CP0	C0332282	atributo	302-312	161_QUEST_clinical_caseMIR	SENT4	-	-
6	afirmaciones	afirmación	NCFP000	-	-	313-325	161_QUEST_clinical_caseMIR	SENT4	-	-
7	es	ser	VSIP3S0	-	-	326-328	161_QUEST_clinical_caseMIR	SENT4	-	-
8	FALSA	falso	AQ0FS0	C0205237	calificador	329-334	161_QUEST_clinical_caseMIR	SENT4	-	-
9	respecto	respecto	NCMS000	-	-	335-343	161_QUEST_clinical_caseMIR	SENT4	-	-
10	al	al	SP+DA	C0441942_1	estadificación_tumoral_1	344-346	161_QUEST_clinical_caseMIR	SENT4	-	-
11	diagnóstico	diagnóstico	NCMS000	C0441942_2	estadificación_tumoral_2	347-358	161_QUEST_clinical_caseMIR	SENT4	-	-
12	de	de	SPS00	C0332285	atributo	359-361	161_QUEST_clinical_caseMIR	SENT4	-	-
13	PTI	pti	NC00YL0	C0398650_1	trastorno_1	362-365	161_QUEST_clinical_caseMIR	SENT4	B-Grp_Enfermedad	-
14	?	?	Fit	-	-	365-366	161_QUEST_clinical_caseMIR	SENT4	-	-
15	.	.	Fp	-	-	366-367	161_QUEST_clinical_caseMIR	SENT4	-	-

